Heal House Vitiligo Research 10 · Original Article
How effective is the PALLAS laser for vitiligo treatment?
The Efficacy of a Gain-Switched 311-nm Titanium:Sapphire Laser in the Treatment of Vitiligo: A Pilot Study of 14 Patients
Last reviewed
In short
This is a pilot study that first examined the efficacy and safety of a newly attempted PALLAS laser (311nm) for vitiligo treatment in 14 patients.
Having one more good treatment tool means one more opportunity for patients. The standard treatment for restoring color in vitiligo is the 308nm excimer laser. I was curious whether the new PALLAS laser, which emits a similar wavelength, could become another option. As a first step, I cautiously examined the efficacy and safety of this laser in 14 patients.
Q1 What Is PALLAS Laser Treatment?
The PALLAS laser is a narrowband ultraviolet laser used to restore color in vitiligo. It emits a wavelength very close to that of the 308nm excimer laser, which is widely used for vitiligo. Additionally, it can focus light on lesions in a laser-specific manner. The goal is to precisely deliver light to small areas, stimulating dormant pigment cells to induce repigmentation. This pilot study was the first attempt to assess whether this new tool is actually useful for vitiligo.
Q2 What Is a Pilot Study and Why Is It Important?
A pilot study is an initial step that examines the efficacy and safety of a new treatment in a small number of patients before full-scale validation. I observed whether this laser showed a response in vitiligo and whether there were any significant side effects in 14 patients. Because the scale is small, definitive conclusions cannot be drawn. Its significance lies in determining whether it is worth proceeding to the next, more rigorous study. In fact, this pilot study served as a stepping stone, leading to a subsequent clinical trial that directly compared the PALLAS laser with the 308nm excimer laser. It is a study that took the first step toward establishing a new treatment.
Closing remarks
For a new treatment to become established for patients, multiple stages of validation are needed. This study was the first step. Although small in scale, it confirmed the potential of the PALLAS laser for the first time. This foundation allowed for a more rigorous clinical trial later. This cautious first attempt is meaningful to me because it ultimately opens up new options for patients.
